KO / EN

We develop
Digital Therapeutics for patients with neurodegenerative diseases

History, Investment, and News

During the past year, Emocog raised funds and

established partnerships with renowned companies worldwide.

Company

2021

  • Emocog, founded (2021.01.19)

  • Certified research facility, established

  • DTA (Digital Therapeutics Alliance) Membership

  • Venture company certification

  • ‘Excellence Award’ recognized by Seoul SMEs and Startups

Seed Funding Round

  • Naver-Stonebridge

  • Kakao-Shinhan Bank

  • Naver D2SF

2022

Pre-Series A Funding Round

  • Naver-Stonebridge

  • Kakao-Shinhan Bank

  • SV Investment

  • Green Cross Holdings

  • ‘Best Company Award’ recognized by Seoul Startup Hub

  • Emocog Germany branch, established

  • Emocog Germany branch accepted to 5-HT hub by 

  • German Ministry of Economic Affairs

Partners

Our Leaders

The founders of Emocog are all medical professors and experts. Our employees are from leading companies around the world, united by a global mindset and a strong passion for what we do.

Leadership

Founder

Jun Young Lee

MD, PhD

Seoul National University College of Medicine, PhD (Psychiatry)

Professor at Seoul National University College of Medicine (Psychiatry)

Korean Elderly Psychiatric Association

Director of Society for Cognitive Intervention

Founder

Yoo Hun Noh

PhD

Chung-Ang University College of Medicine, PhD

Former Professor at Chung-Ang University College of Medicine (Human Anatomy)

Consulting Member at KISTEP

Founder

Jung Hae Youn

PhD

Paris 7, PhD

CEO of Cha Psychological Counseling Center

Professor at Cha University College of Medicine (Psychology)

Chief Operating Officer

Seul Gyu Park

Sciences Po Paris, Master’s

(Business Management)

M&A, Finance & Corporate Strategy

Former Big 4 Management Consulting

Chief Strategy Officer / CEO Europe

Johannes Funk

Heidelberg University, Bachelor’s (Economics)

M&A, Finance & Corporate Strategy

Sciences Po Paris Master’s (Economics/Business Management)

Former M&A and Finance at Siemens, Germany, Portugal & Switzerland

EVP / Chief Medical Officer

June Sik Mune

MD, PhD

Seoul National University College of Medicine, Bachelor's

Soonchunyang University College of Medicine, PhD

Former LG Chem, Head of Clinical Development Center

Chief Business Officer

Brian Lim

Korea University, Bachelor’s

(Business Management)

Merck-Harvard Executive Business School

Former Head of Domestic and International Strategy, Business Development, Marketing, Sales at Global Pharmaceutical Company, Merck (MSD)

Chief Technology Officer

Joonsang Jo

Seoul National University, Bachelor’s

(English Language Education, Computer Science and Engineering)

Former SAP Software Engineer

Solution

Dementia Solutions

Cogthera

Cogthera constantly monitors the conditions of patients' cognitive functions and provides personalized cognitive training to strengthen the neural networks, which increases the 'cognitive reserve' and helps with memory.
The app's contents are derived from the concept of Metamemory training, the subject of our founders' long-year research.

*Cognitive reserve: a concept introduced from the distinction between neuropathological and clinical severity of the brain;

one of the factors that determine the prevention and prognosis of dementia.

*Metamemory training provides specific strategies for memory improvement in patients with early signs of cognitive decline (e.g., MCI) by strengthening the brain structure that is responsible for memory functions(i.e. hippocampus) and the integrated neural networks.

Software as a Medical Device
for enhancing early cognitive decline

1

01

Conversation-based interface using vocal cues,
made for the convenience of patients with early cognitive decline.

02

After accurate assessments of the patient’s cognitive ability, training contents are automatically generated via AI technology, providing personalized training with difficulty adjustments.

03

Frees the patient from restraints of professional presence, location, and time.
 Accessible anytime and anywhere.

Why Emocog

We create technology

that helps sustain

brain health

About 10% of the senior population suffers from dementia. Yet, many patients begin to encounter issues with memory loss in the stage before dementia, known as Mild Cognitive Impairment (MCI).

In comparison to dementia, 25% of the senior population suffers from MCI.
 

Emocog currently develops Digital therapeutics,
aiming to enhance the cognitive functions of patients in an early stage of cognitive decline.

Why Emocog

Digital Therapeutics

that can be trusted,
developed by

dementia experts

Managing, i.e., proactively taking care of and training cognitive function is just as important as medicine for dementia patients.
We came up with a digital therapeutics product with the concept of a 'digital coach' supporting patients in managing their cognitive functions, available anytime and anywhere.


Emocog provides reliable and personalized solutions to treat cognitive decline by training the brain using digital technology developed by dementia specialists.

Research

Technology
based on world-class scientific results

The results of 20 years of research have been published in
5 leading SCI-indexed journals on brain disease.

*Science Citation Index (SCI): renowned journals carefully selected
based on a strict criteria among science and technology journals

Cogcare

Cogcare consists of Medi-ballet and MMT.

Medi-ballet is a ballet program for the elderly aiming to improve memory by training the body and memory.
Improve your symptoms and upgrade your quality of life with Medi Ballet.

MMT is a training program based on ‘metamemory’ that enhances the cognitive function of the elderly with the help of cognitive training experts.

Memory and cognitive enhancement program

2

News

career.png

Come and make a new history

with Emocog

Hiring All Positions Now

We develop
‘Digital Therapeutics’ for patients with neurodegenerative diseases

Why Emocog

We create technology that helps sustain brain health

About 10% of the senior population suffers from dementia. Yet, many patients begin to encounter issues with memory loss in the stage before dementia, known as Mild Cognitive Impairment (MCI). In comparison to dementia, 25% of the senior population suffers from MCI.

Emocog currently develops Digital therapeutics, aiming to enhance the cognitive functions of patients in an early stage of cognitive decline.

Why Emocog

Digital Therapeutics that can be trusted, developed by dementia experts

Managing, i.e., proactively taking care of and training cognitive function is just as important as medicine for dementia patients.

We came up with a digital therapeutics product with the concept of a ‘digital coach’ supporting patients in managing their cognitive functions, available anytime and anywhere.


Emocog provides reliable and personalized solutions to treat cognitive decline by training the brain using digital technology developed by dementia specialists.

Research

Technology
based on world-class scientific results

The results of 20 years of research have been published in 5 leading SCI-indexed journals on brain disease.

*Science Citation Index (SCI): renowned journals carefully selected based on a strict criteria among science and technology journals

Solution

Dementia Solutions

1

Cogthera

Cogthera constantly monitors the conditions of patients’ cognitive functions and provides personalized cognitive training to strengthen the neural networks, which increases the ‘cognitive reserve’ and helps with memory.
The app’s contents are derived from the concept of Metamemory training, the subject of our founders’ long-year research.

Software as a Medical Device
for enhancing early cognitive decline

*Metamemory training provides specific strategies for memory improvement in patients with early signs of cognitive decline (e.g., MCI) by strengthening the brain structure that is responsible for memory functions

(i.e., hippocampus) and the integrated neural networks.

*Cognitive reserve: a concept introduced from the distinction between neuropathological and clinical severity of the brain. One of the factors that determines the prevention and prognosis of dementia.

01

Conversation-based interface using vocal cues, made for the convenience of patients with early cognitive decline.

02

After accurate assessments of the patient’s cognitive ability, training contents are automatically generated via AI technology, providing personalized training with difficulty adjustments.

03

Frees the patient from the restraints of professional presence, location, and time.
Accessible anytime and anywhere.

*Cogcare consists of Medi-ballet and Memory Lane

2

Cogcare

Medi-ballet is a ballet program for the elderly seeking to improve their memory by training the body and memory. Upgrade your quality of life with Medi Ballet.

Memory Lane is a training program based on ‘metamemory’ that enhances the cognitive function of the elderly with the help of cognitive training experts.

Memory and cognitive enhancement program

Our Leaders

The founders of Emocog are all medical professors and experts.

Our employees are from leading companies around the world, united by a global mindset and a strong passion for what we do.

Leadership

Founder

Jun Young Lee

MD, PhD

Founder

Yoo Hun Noh

PhD

Founder

Jung Hae Youn

PhD

Chief Strategy Officer

CEO Europe

Johannes Funk

MSc

History, Investment, and News

During the past year, Emocog raised funds and established partnerships with renowned companies worldwide.

Company

2021

  • Emocog, founded (2021.01.19)

  • Certified research facility, established

  • DTA (Digital Therapeutics Alliance) Membership

  • Venture company certification

  • ‘Excellence Award’ recognized

         by Seoul SMEs and Startups

Seed Funding Round

  • Naver-Stonebridge

  • Kakao-Shinhan Bank

  • Naver D2SF

2022

  • ‘Best Company Award’ recognized

         by Seoul Startup Hub

  • Emocog Germany branch, established

Pre-Series A Funding Round

  • Naver-Stonebridge

  • Kakao-Shinhan Bank

  • SV Investment

  • Green Cross Holdings

Partners

News

career.png

Come and make

a new history

with Emocog

Hiring All Positions Now

© 2022 Emocog Inc. All Rights Reserved.

Contact

E. contact@emocog.com

T. +82 2 6745 0001

Emocog Lab

서울시 마포구 공덕동 백범로31길 21,

서울창업허브, 804 (04147)

© 2022 Emocog Inc. All Rights Reserved.

Contact

E. contact@emocog.com

T. +82 2 6745 0001

Emocog Lab

서울시 마포구 공덕동 백범로31길 21,

서울창업허브, 804 (04147)

© 2022 Emocog Inc. All Rights Reserved.

Emocog Lab

서울시 마포구 공덕동 백범로31길 21,

서울창업허브, 804 (04147)

Contact

E. contact@emocog.com

T. +82 2 6745 0001

© 2022 Emocog Inc. All Rights Reserved.

Contact

E. contact@emocog.com

T. +82 2 6745 0001

Emocog Inc. 

411 Ho, 7, Boramae-ro 5ga-gil, Gwanak-gu, Seoul, Republic of Korea (07071)

Emocog Lab

804 Ho, 21, Baekbeom-ro 31-gil, Mapo-gu, Seoul, Republic of Korea (04147)

Emocog Inc.

HERE-RO3   404 Ho, 117, Sillim-ro, Gwanak-gu, Seoul, Republic of Korea (08813)

804 Ho, 21, Baekbeom-ro 31-gil, Mapo-gu, Seoul, Republic of Korea (04147)

Emocog Lab

Contact

E. contact@emocog.com

T. +82 2 6745 0001

© 2022 Emocog Inc. All Rights Reserved.